Terumo Corporation to acquire CaridianBCT
Japan's Terumo Corporation is to acquire US firm Caridian BCT.
Merger and acquisitions advisers could be required after Japan's Terumo Corporation revealed it has entered into a Stock Purchase Agreement to acquire CaridianBCT.
The US medical equipment company is to be purchased from its current owners, Sweden's Gambro, in an effort to boost its stature in the global blood transfusion products market.
"The Acquisition of CaridianBCT is highly complementary with Terumo. Terumo will combine its expertise in whole blood collection with CaridianBCT's extensive experience and exceptional quality," said CaridianBCT.
It went on to state that the acquisition will see Terumo's sales composition in this area grow by ten per cent, enabling the sector to serve as a "new core business for global growth".
Terumo started life as a clinical thermometer manufacturer in 1921 and has since grown exponentially, branching out into areas such as hollow-fiber technology, blood-management systems and endovascular therapy.
Last month saw Swiss chemical specialist Clariant acquire its German counterpart Sued-Chemie following successful sales negotiations.